Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sonoma Pharmaceuticals (SNOA) Times Interest Earned (2016 - 2021)

Sonoma Pharmaceuticals has reported Times Interest Earned over the past 12 years, most recently at -$904.0 for Q2 2021.

  • For Q2 2021, Times Interest Earned changed N/A year-over-year to -$904.0; the TTM value through Mar 2022 reached -$5886.0, down 1436.37%, while the annual FY2021 figure was -$287.42, 37.77% up from the prior year.
  • Times Interest Earned for Q2 2021 was -$904.0 at Sonoma Pharmaceuticals, down from -$27.6 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $42.25 in Q3 2020 and troughed at -$2912.0 in Q1 2017.
  • A 5-year average of -$602.75 and a median of -$358.58 in 2017 define the central range for Times Interest Earned.
  • Biggest five-year swings in Times Interest Earned: crashed 230.04% in 2019 and later skyrocketed 106.57% in 2020.
  • Year by year, Times Interest Earned stood at -$290.91 in 2017, then fell by 15.4% to -$335.71 in 2018, then tumbled by 230.04% to -$1108.0 in 2019, then surged by 97.51% to -$27.6 in 2020, then crashed by 3175.36% to -$904.0 in 2021.
  • Business Quant data shows Times Interest Earned for SNOA at -$904.0 in Q2 2021, -$27.6 in Q4 2020, and $42.25 in Q3 2020.